Author:
Božičević L.,Vrček V.,Peranić N.,Kalčec N.,Hildebrandt J.,Altmann K.,Vrček I. Vinković
Reference8 articles.
1. ‘Environmental Impacts of Microplastics and Nanoplastics: A Current Overview’;Amobonye;Frontiers in Microbiology,2021
2. ‘Pharmaceuticals in the Environment – Global Occurrences and Perspectives’;aus der Beek;Environmental Toxicology and Chemistry,2016
3. ‘Medicating the Environment? A Critical Review on the Risks of Carbamazepine, Diclofenac and Ibuprofen to Aquatic Organisms’;Batucan,;Environmental Advances,2022
4. ‘Environmental Risk Assessment for the Serotonin Re Uptake Inhibitor Fluoxetine: Case Study Using the European Risk Assessment Framework’;Oakes,;Integrated Environmental Assessment and Management,2010
5. OECD, 2021, Test No. 455: Performance-Based Test Guideline for Stably Transfected Transactivation In vitro Assays to Detect Estrogen Receptor Agonists and Antagonists, OECD Guidelines for the Testing of Chemicals, Section 4, OECD